Chemcrux Enterprises Limited

CHEMCRUX6

INE298W01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:53 16/07/2024 pm IST			5-day change	1st Jan Change
235.6 ^INR	-0.38%		-1.87%	-23.34%

06/05	Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2023-24	CI
06/05	Chemcrux Enterprises Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Chemcrux Enterprises Limited has filed an IPO in the amount of INR 24.048 million.

January 16, 2017 at 10:30 am IST

Chemcrux Enterprises Limited has filed an IPO in the amount of INR 24.048 million. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 1,336,000 PriceRange: INR 18 Transaction Features: Regulation S

Latest news about Chemcrux Enterprises Limited

Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2023-24	06/05	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	06/05	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02	CI
Chemcrux Enterprises Names CFO	08/12	MT
Chemcrux Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Chemcrux Enterprises Limited Announces Resignation of Mr. Krutarth Parikh as Chief Financial Officer, Effective 13 September 2023	01/23/01	CI
Chemcrux Enterprises Limited Announces Board Changes	04/23/04	CI
Chemcrux Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	04/23/04	CI
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2022-23	20/23/20	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	12/22/12	CI
Chemcrux Enterprises Limited Appoints Mukund Prahlad Bakshi as Independent Director	24/22/24	CI
Chemcrux Enterprises Limited Approves Final Dividend for the Financial Year Ended 31 March 2022	24/22/24	CI
Chemcrux Enterprises Limited Proposes Final Dividend for the Financial Year Ended 31 March 2022	31/22/31	CI
Chemcrux Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12/22/12	CI
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2021-22	20/22/20	CI
Chemcrux Enterprises Gets Local Bourse BSE's Approval in Principle to Move to Main Board	29/22/29	MT
Chemcrux Enterprises Gets Environment Clearance to Expand Manufacturing of Synthetic Organic Chemicals	04/22/04	MT
Chemcrux Enterprises and Kalintis Healthcare to Set Up New Joint Venture	22/21/22	MT
Chemcrux Enterprises Limited Announces Resignation of Sidhdhi Girishkumar Shah as Non-Executive Non-Independent Director	22/21/22	CI
Chemcrux Enterprises Limited Appoints Mukund Prahlad Bakshi as an Additional Director	22/21/22	CI
Chemcrux Enterprises Limited completed the acquisition of a 50% stake in Kalichem Private Limited.	22/21/22	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Half Year Ended September 30, 2021	01/21/01	CI
Chemcrux Enterprises : to Acquire 50% Stake in Indian Chemicals Manufacturer	08/21/08	MT
Chemcrux Enterprises Limited (BSE : 540395) agreed to acquire a 50% stake in Kalichem Private Limited.	08/21/08	CI

Chart Chemcrux Enterprises Limited

Duration

Period

More charts

Company Profile

Chemcrux Enterprises Limited is an India-based company. The Company is engaged in manufacturing intermediates for bulk drugs, dyes and pigment industries. It is engaged in manufacturing or processing of bulk drug intermediates like Para Chloro Benzoic, Ortho Benzoic Acid, and Lasamide, among others. The Company's products include 2 Chloro Benzoic Acid, 3 Chloro Benzoic Acid, 4 Chloro Benzoic Acid, 2,4 Dichloro Benzoic Acid, 4 Chloro 3 Nitro Benzoic Acid; 2 Chloro 5 Nitro Benzoic Acid; Meta Nitro Benzoic Acid; Lasamide, and Meta Chloro Per Benzoic Acid. It is engaged in development and execution of various processes, such as High-Pressure Oxidation, Nitration, Amidation, BPEA Sulfonamide and Chlorosulfonation. The Companyâs manufacturing facility is located in Bharuch, Gujarat, India.

Sector

Pharmaceuticals

Calendar

09/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHEMCRUX ENTERPRISES LIMITED	-23.34%	41.92M
ELI LILLY AND COMPANY	+62.04%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-4.06%	359B
MERCK & CO., INC.	+15.35%	325B
ABBVIE INC.	+9.05%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.94%	177B
PFIZER, INC.	+2.26%	165B